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Interferon g Induces the Expression of p21waf-1
and Arrests Macrophage Cell Cycle,
Preventing Induction of Apoptosis
When cells enter the cycle from quiescence (G0), during
the G1 interval, D-type and E-type cyclins are sequen-
tially synthesized (Matsushime et al., 1991); both cyclins
are rate limiting for entry in the S phase. D-type cyclins
are regulated by extracellular signals, whereas the ex-
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Campus de Bellvitge periodic. Unlike other cdks, cyclin D±dependent kinases
Universitat de Barcelona have a distinct substrate preference for the retinoblas-
Avenida Diagonal 645 toma protein (pRb) (Matsushime et al., 1992). pRb binds
08028 Barcelona and negatively regulates transcription factors that are
Spain necessary for S phase entry (Sherr, 1994b). However, the
phosphorylation of pRb by cyclin D/E-cdk complexes
at or near the R point cancels its growth-suppressive
function, thus releasing the transcription factors and
Summary allowing them to activate genes necessary for S phase
entry (Sherr and Roberts, 1995).
Incubation of bone marrow macrophages with lipo- Recently, two families of mammalian G1 cdk inhibi-
polysaccharide (LPS) or interferon g (IFNg) blocks mac- tors, the CIP/KIP (p21, p27, and p57) and the INK-4 (p15,
rophage proliferation. LPS treatment or M-CSF with- p16, p18, and p19), have been described (reviewed in
drawal arrests the cell cycle at early G1 and induces Sherr and Roberts, 1995). These inhibitors help to ex-
apoptosis. Treatment of macrophages with IFNg stops plain how antiproliferative signals arrest cells in G1 and
the cell cycle later, at the G1/S boundary, induces also the arrest induced by DNA damage, terminal differ-
p21Waf1, and does not induce apoptosis. Moreover, pre- entiation, or cell senescence. These cdk inhibitors bind
treatment of macrophages with IFNg protects from to cyclin-cdk complexes, particularly to G1-cyclin-cdk
apoptosis induced by several stimuli. Inhibition of complexes, thus inducing cell cycle arrest.
p21Waf1 with antisense oligonucleotides or using KO Apoptosis is a genetically controlled process of pro-
mice shows that the induction of p21Waf1 by IFNg medi- grammed cell death. Recently, genes important for the
ates this protection. Thus, IFNg makes macrophages regulation of apoptosis have been identified (White,
unresponsive to apoptotic stimuli by inducing p21Waf1 1996). These include many genes first thought to be
and arresting the cell cycle at the G1/S boundary. involved in cell growth and differentiation (Vaux and
Therefore, the cells of the innate immune system could Strasser, 1996). Apoptosis sustains tissue homeostasis
only survive while they were functionally active. by balancing the proliferative capabilities of different
cells. Thus, cells with a higher proliferation rate are more
susceptible to apoptosis. The regulatory coupling of
Introduction
proliferation and apoptosis is suggested by several ob-
servations. For example, the expression of the protoon-
Under different external stimuli, cells are able to prolifer-
cogene c-myc stimulates cell proliferation and can alsoate, to become activated and carry out their function, to
predispose cells toward apoptosis when growth factorsremain quiescent, or to die through apoptosis. Although
are scarce (Evan et al., 1992). Moreover, the activationthese events were initially considered as independent,
of the expression of cyclin D (Freeman et al., 1994) orrecent reports have shown a cross-talk between the
the activation of various cdks has been linked with theproliferative capacity of the cells and their activation
induction of apoptosis (Meikrantz et al., 1994; Shi et al.,or susceptibility to die through apoptosis. Thus, many
1994; Wei et al., 1997; Zhang et al., 1997). More recentmechanisms that induce cells to proliferate or become
work now indicates that the apoptosis regulatory pro-activated also induce them to undergo apoptosis (Evan
teins themselves can also directly modulate the cell cy-et al., 1992; Meikrantz and Schlegel, 1995; Zhu and Ana-
cle progression of the cells (Brady et al., 1996; Linettesetti, 1995; Levkau et al., 1998).
et al,. 1996; Mazel et al., 1996; O'Reilly et al., 1996).The commitment of cells to enter the S phase of the
Whereas antiapoptotic genes like bcl-2 delay cell cyclecell cycle occurs at a restriction point (R) late in G1
progression, bax and other proapoptotic genes increasephase, after which the cells do not need mitogenic
the number of cycling cells.growth factors to complete division (Pardee, 1989). The
To carry out their functional activities, macrophagesprogression from the G1 to the S phases is controlled
have to become activated. After interacting with IFNg,by G1 cyclins that bind to cdks (cyclin-dependent ki-
a cytokine released by activated T lymphocytes, thenases) to form holoenzymes that phosphorylate sub-
macrophages undergo biochemical and morphologicalstrates that facilitate the progression (Sherr, 1994a).
modifications that allow them to perform their functional
activity (Schreiber and Celada, 1985). Although IFNg is
the major macrophage activator, other molecules such* To whom correspondence should be addressed (e-mail: acelada@
bio.ub.es). as lipopolysaccharide (LPS), the main component of
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Figure 1. LPS and IFNg Inhibit M-CSF-Dependent Proliferation of Macrophages
(A) M-CSF-dependent 3H-Thymidine incorporation in macrophages. BMDM were grown for 5 days before measuring thymidine incorporation
as indicated in the Experimental Procedures. The cells were incubated for 24 hr with different concentrations of M-CSF alone (M-CSF) or
supplemented with saturating amounts of IFNg (250 U/ml) (M-CSF 1 IFNg) or LPS (100 ng/ml) (M-CSF 1 LPS). This figure represents one of
four independent experiments with the standard error of triplicates for each point. (B) Time course of IFNg and LPS inhibition of cell proliferation.
Macrophages growing in the presence of 1200 U/ml of M-CSF were treated with 250 U/ml IFNg or 100 ng/ml LPS. 3H-Thymidine was added
at 3 hr intervals, and samples were fixed after 2 additional hr of incubation. (C) Cell cycle analysis of BMDM treated with M-CSF, M-CSF
starvation, M-CSF 1 IFNg, and M-CSF 1 LPS. Macrophages growing in the presence of 1200 U/ml M-CSF (M-CSF), treated for 24 hr with
250 U/ml of IFNg (M-CSF 1 IFNg), 6 hr with 100 ng/ml LPS (M-CSF 1 LPS), or starved of M-CSF for 24 hr were washed, stained with DAPI,
and fixed. The DNA content was measured using a flow cytometer. Exponentially growing cells appear in the graph with two peaks corresponding
to cells in G0/G1 phase (G) and cells with double DNA content in G2/M phase (I). Apoptotic cells appear as a peak to the left of the G0/G1 peak
due to their lower DNA content (H). (D) Northern blot analysis of the effect of M-CSF starvation, IFNg, or LPS on different components of the
cell cycle. (E) Effect of M-CSF starvation, IFNg, or LPS on cdk2 kinase activity. Kinase activity was assayed by immunoprecipitation of cdk2
and using Histone H1 as a substrate of phosphorylation. (F) Counting of viable cells after M-CSF starvation, IFNg, or LPS treatment measured
by Trypan blue exclusion and using a hemocytometer. Each point was performed in triplicate, and the results were represented as the
mean 6 SD.
the wall of gram-negative bacteria, can induce some Results
aspects of macrophage activation.
We studied how and by which mechanism IFNg modu- In our studies, we used bone marrow±derived macro-
phages, which are a homogeneous population of pri-lates cell proliferation and apoptosis using bone mar-
row±derived macrophages (BMDM) as a model. These mary and quiescent cells. When treated with M-CSF,
macrophages proliferate in a dose-dependent mannerare nontransformed cells that, when activated with LPS
or interferon g (IFNg), inhibit macrophage-colony stimu- (Figure 1A), and withdrawal of M-CSF induces an arrest
of macrophage proliferation. Two macrophage activa-lating factor (M-CSF)-dependent proliferation. However,
whereas these cells undergo apoptosis with LPS, mac- tors, IFNg and LPS, inhibit M-CSF-dependent prolifera-
tion (Figures 1A and 1B). After the addition of IFNg orrophages treated with IFNg are not apoptotic. In fact,
treatment of these cells with IFNg protects them from LPS, the proliferation of macrophages decreases pro-
gressively at 12±15 hr. Therefore, macrophages eitherapoptosis induced by LPS, growth factor deprivation,
or dexamethasone. IFNg induces p21Waf1 expression, the proliferate with M-CSF or they become activated with
IFNg or LPS and thus stop proliferating.repression of which abrogates the protective effect of
IFNg on apoptosis. Our results demonstrate that the Macrophages growing in the presence of M-CSF
showed a homogeneous distribution throughout the cellexpression of p21Waf1 and the blocking of the cell cycle
at the G1/S boundary make the cells unresponsive to cycle (Figure 1C). M-CSF starvation stopped the cell
cycle at the beginning of G1. Although both IFNg andapoptotic stimuli.
IFNg Induces p21 and Blocks Induction of Apoptosis
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Figure 2. IFNg Protects Macrophages against
Apoptosis
(A) M-CSF starvation or treatment with LPS
or dexamethasone induces macrophage apo-
ptosis. Macrophages growing in the pres-
ence of 1200 U/ml of M-CSF were treated for
12 hr with 250 U/ml IFNg, 100 ng/ml LPS,
or 10 mg/ml dexamethasone or grown in the
absence of M-CSF for 24 hr. Apoptosis was
determined visualizing DNA fragmentation.
(B) IFNg protects macrophages against apo-
ptosis induced by M-CSF starvation. Expo-
nentially growing BMDM in the presence of
M-CSF were cultured without M-CSF for 0,
12, 24, and 36 hr. These cells were supple-
mented with or without 250 U/ml of IFNg dur-
ing this period of starvation. Apoptosis was
determined by apoptotic DNA laddering us-
ing agarose gel electrophoresis. These ex-
periments were performed at least three
times with similar results.
(C) IFNg and the growth factors GM-CSF and
IL-3 protect M-CSF starved macrophages
from apoptosis. Macrophages were cultured
with M-CSF for 24 hr (1 M-CSF) or in the
absence of M-CSF but with the media supple-
mented with 250 U/ml of IFNg or 10 ng/ml of the following: GM-CSF, IL-3, IL-4, or TGFb. The induction of apoptosis measured as DNA
fragmentation was analyzed using an ELISA kit. Each treatment was performed three times, and the results were represented as the mean
value plus standard error. (D) IFNg protects macrophages from LPS-induced apoptosis. Macrophages were pretreated with 250 U/ml of IFNg
or 10 ng/ml of GM-CSF, IL-3, IL-4, or TGFb for 12 hr in presence of 1200 U/ml M-CSF and then stimulated with 100 ng/ml of LPS for 6 more
hr. Apoptosis was determined as in (C).
LPS activate macrophages, they inhibited proliferation IFNg and LPS decreased cdk-2 activity, which is neces-
sary for entry and passage through the S phase of theand blocked the cell cycle at different points. Inhibition
cell cycle.by LPS occurred at the beginning of the G1 phase (Figure
All cell types require specific factors to remain viable,1C), close to where the cell cycle is inhibited by M-CSF
and the withdrawal of these factors results in apoptoticwithdrawal. However, IFNg blocked the cell cycle later,
cell death (Sachs and Lotem, 1993). Nontransformedat the G1/S boundary (Figure 1C). Although some cells
macrophages are not an exception to this rule and re-were in S phase after IFNg treatment, they did not incor-
quire the presence of M-CSF for proliferation and sur-porate thymidine, and the total number of cells did not
vival (Tushinski and Stanley, 1985). After M-CSF with-increase after 24 hr (Figure 1F). These results are in accor-
drawal, the analysis of the cell DNA content showed adance with the time elapsed until macrophages reen-
subdiploid peak corresponding to apoptotic cells (Fig-tered the S phase, after the end of LPS or IFNg blockage;
ure 1C). After 24 hr of M-CSF withdrawal, this affectedi.e., 8 and 1 hr later, respectively (Vadiveloo et al., 1996),
around 25% of the total macrophage population. Be-thus indicating the relative position of these blocking
sides, the treatment for 6 hr with 100 ng/ml LPS clearlypoints within the G1 phase.
induced a subdiploid peak corresponding to apoptoticNext, we analyzed the expression of different cell cy-
cells for more than 35% of the total macrophage popula-cle genes that might be modulated by IFNg, LPS, or
tion. However, the treatment with IFNg for up to 24 hrM-CSF withdrawal to inhibit proliferation. The cell cycle
had little effect on the induction of apoptosis (Figureblock induced by M-CSF starvation was caused by an
1C). Moreover, the analysis of the number of survivinginhibition of cyclin D1 gene expression (64% inhibition)
cells after these treatments confirmed that whereas
(Figure 1D; Matsushime et al., 1991) similar to that in-
M-CSF withdrawal or LPS treatment reduced the num-
duced by LPS (72% inhibition). LPS also inhibited cdk-4 ber of viable cells after 24 and 48 hr, IFNg did not modify
gene expression (71%). Neither M-CSF withdrawal nor the initial number of cultured cells but inhibited their
LPS significantly modified p21Waf1 gene expression. proliferation in the presence of M-CSF (Figure 1F). DNA
However, IFNg induced a transient expression of p21Waf1, laddering analysis confirmed the induction of apoptosis
a dual inhibitor of cyclin-dependent kinases (3.4-fold by LPS and M-CSF starvation and the absence of IFNg
increase at 6 hr) (Gu et al., 1993; Harper et al., 1993; effect. The apoptotic gene Bax was particularly induced
Xiong et al., 1993). The analysis of the expression of in cells treated with LPS or M-CSF withdrawal, whereas
cyclin D1 and cdk-4 mRNA (Figure 1D) or the formation no induction was observed in IFNg treated macrophages
of these complexes by immunoprecipitation and immu- (data not shown). Besides, we observed that 10 mg/
noblotting revealed that neither is significantly modified ml dexamethasone also induced apoptosis in BMDM
by IFNg (data not shown). Moreover, both LPS and IFNg (Figure 2A).
inhibited the expression of the protooncogene c-myc. Although both the endogenous (IFNg) and the exoge-
We also analyzed the kinase activity of cdk2 using His- nous (LPS) macrophage activators blocked cell prolifer-
ation, the difference observed in the capacity to inducetone H1 as a substrate (Figure 1E). As expected, both
Immunity
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apoptosis led us to study the effects of IFNg on agents
that induce apoptosis in macrophages. As shown in
Figure 2B, M-CSF deprivation induced in BMDM an in-
ternucleosomal pattern of DNA fragmentation (DNA lad-
dering) detectable after 24 hr, with a maximum at 36 hr.
In a parallel experiment, IFNg (250 U/ml) was added to
macrophages simultaneously to M-CSF removal. Under
these conditions, IFNg protected against apoptosis in-
duced by M-CSF starvation (Figure 2B). The incubation
of macrophages with 250 U/ml IFNg suppressed the
fragmentation of the DNA during the induction of apo-
ptosis at all the time points tested during 48 hr of M-CSF
deprivation. We also studied whether other cytokines
besides IFNg inhibited the induction of apoptosis by
M-CSF starvation (Figure 2C). The induction of apo-
ptosis, as described in the Experimental Procedures,
was measured as the quantitation of DNA fragmentation
using an ELISA technique (Boehringer Mannheim). Only
growth factors GM-CSF and IL-3 protected starved
macrophages against apoptosis, whereas IL-4 and
TGFb did not. Both GM-CSF and IL-3 induce macro-
phage proliferation in the absence of M-CSF (Celada
and Maki, 1992). To determine if the protective effect of
IFNg on apoptosis in macrophages was related solely to
the withdrawal of M-CSF, we tested LPS as an apoptotic
stimulus. As shown in Figure 2D, IFNg also protected
LPS-mediated apoptosis. To protect against LPS-induced
apoptosis, macrophages must be pretreated for 12 hr
with IFNg. None of the other growth factors or cytokines
tested protected against the induction of apoptosis by
Figure 3. Time Course of IFNg Protection against Apoptosis In-100 ng/ml LPS when they were administered 12 hr before
duced by LPS or DexamethasoneLPS (Figure 2D). Moreover, IFNg also protected macro-
(A) Time of preincubation with IFNg required to protect against LPS-phages against apoptosis induced by dexamethasone
or dexamethasone-induced apoptosis. BMDM were preincubated(Figure 3A). Thus, IFNg protected specifically against
with IFNg (250 U/ml) for the indicated time and then LPS (100 ng/
apoptosis induced by different stimuli in macrophages. ml) or dexamethasone (10 mg/ml) was added and the cells were
The inhibitory effect of IFNg on the M-CSF-dependent incubated for 6 more hr. Apoptosis was determined using an ELISA
proliferation is not immediate and requires several hours kit. Each treatment was performed three times, and the results were
represented as the mean value plus standard error. (B) Time courseof treatment. At least 12 hr of pretreatment with IFNg
of IFNg-induced expression of p21Waf1 mRNA. BMDM were incubatedwas needed to protect against LPS- or dexamethasone-
with IFNg (250 U/ml) for different periods of time and then the expres-induced apoptosis; besides, the protection of IFNg against
sion of p21Waf1 was determined by Northern blotting or Westernapoptosis was not effective when both activators were
blotting (C). p27kip1 expression was also analyzed by Western
added at the same time (Figure 3A). These results led blotting.
us to study a possible relationship between cell cycle
progression and protection against apoptosis. As treat-
of proliferation and the expression of p21waf1. To deter-ing macrophages with IFNg induces a stop of the cell
mine if the protective effects of IFNg are only causedcycle at the G1/S boundary, we analyzed the expression
by the induction of p21waf1 or by the expression/repres-of G1 cyclin-dependent kinases and cell cycle regulatory
sion of other genes, we designed an experiment to blockproteins involved in the G1 progression, which could
the induction of p21waf1 by IFNg using antisense con-also be regulating apoptosis. IFNg induced in macro-
structions. The expression of p21waf1 was inhibited withphages the expression of p21waf1 without modifying the
an antisense oligonucleotide complementary to a regionlevels of cyclin D1-cdk-4 mRNA expression (Figure 1D).
that includes the initiation codon of p21waf1. A missenseThe IFNg-induced expression of p21waf1 mRNA (Figure
oligonucleotide was used as a control (see the Experi-3B) and protein (Figure 3C) was detected after 2 and 4 hr
mental Procedures). In previous experiments, using fluo-of treatment with IFNg, respectively, and this expression
resceinated oligonucleotides we determined the timewas maintained during the timing of the experiments.
necessary for oligonucleotide uptake by macrophages.IFNg induces the expression of p21waf1 through a p53-
Uptake was detected after 8 hr of incubation andindependent pathway that requires Stat-1 activation
reached a plateau after 24 hr of incubation (data not(Chin et al., 1996). In accordance with this observation,
shown). The experiments summarized in Figure 4 wereno induction of p53 protein expression by IFNg was
carried out by incubating the macrophages for 12 hrdetected (data not shown). Moreover, no induction of
with antisense or missense oligonucleotides, and thenp27Kip1 was observed after treating the macrophages
IFNg was added for 24 hr in the presence of the samewith IFNg (Figure 3C).
oligonucleotides. Under these conditions, antisense oli-The data presented thus far indicate that the protec-
tion of apoptosis by IFNg correlated with the inhibition gonucleotides specifically blocked the expression of
IFNg Induces p21 and Blocks Induction of Apoptosis
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Figure 4. Expression of p21Waf1 Is Required
for the Antiapoptotic Effect of IFNg
(A) Antisense oligonucleotides against p21Waf1
inhibit the IFNg induction of p21Waf1. BMDM
were incubated for 12 hr with media (control),
10 mM antisense, or missense phosphothi-
oated oligonucleotides. Then, IFNg (250 U/ml)
or media was added and p21Waf1 and b-actin
expression were determined by Western blot-
ting 24 hr later.
(B) p21Waf1 antisense blocks the IFNg inhibi-
tion of LPS- or dexamethasone-induced apo-
ptosis. BMDM were incubated with antisense
oligonucleotides as indicated above and pre-
treated or not with 250 U/ml IFNg. The induc-
tion of apoptosis after 6 hr of treatment with
LPS (100 ng/ml) or dexamethasone (10 mg/ml)
was analyzed.
(C) IFNg does not inhibit apoptosis in macro-
phages from p21Waf1 KO mice. IFNg protective
effect was analyzed in BMDM obtained from normal homozygote (1/1), heterozygote (1/2), or knockout (2/2) mice for p21Waf1. Macrophages
were pretreated or not with 250 U/ml IFNg for 24 hr. Then, macrophages were treated for 6 more hr with 100 ng/ml LPS or 10 mg/ml
dexamethasone. Induction of apoptosis was measured as indicated above. Each treatment was performed three times, and the results were
represented as the mean value plus standard error.
(D) IFNg inhibits proliferation in macrophages from p21 KO mice. 105 macrophages from p21 KO or wild-type mice were incubated in 24-well
plates in the presence of 1200 U/ml of M-CSF either alone or with 300 U/ml IFNg. Proliferation was determined as indicated in the Experimental
Procedures. The experiments with the antisense oligonucleotides and p21 KO mice were performed twice, with identical results.
p21waf1 protein induced by IFNg (Figure 4A). In parallel insulin-like growth factor-I (IGF-I) had an increased
p21waf1 mRNA expression (Figure 5A). No such increaseexperiments, after the oligonucleotide incubation, IFNg,
was found when the cells were incubated with epidermalLPS, or dexamethasone was added for 6 hr more. Apo-
growth factor (EGF) in the same conditions. Surprisingly,ptosis was then determined. Neither the antisense nor
and in contrast with what was observed with IFNg, al-the missense oligonucleotides induced apoptosis or
though p21waf1 was induced in macrophages treated withblocked the induction of apoptosis by LPS or dexameth-
IGF-1, no inhibition of M-CSF-dependent proliferationasone. However, the antisense but not the control oligo-
was observed (Figure 5B). Besides, apoptosis inducednucleotides inhibited the protective effect of IFNg on
by LPS or dexamethasone was not inhibited by pretreat-apoptosis induced by LPS or dexamethasone (Figure
ment with IGF-1 (Figure 5C). These results showed that4B). These results suggested that the effect of IFNg
the protective role of p21waf1 on the induction of apo-protecting macrophages against apoptosis was medi-
ptosis is not due to a direct inhibition of apoptosis.ated by p21waf1 expression.
Therefore, p21waf1 was necessary but not sufficient toTo confirm whether induction of p21waf1 is required for
cause a direct inhibition of apoptosis, and it seemedthe protective effect of IFNg on apoptosis, we carried out
that, at least, the cell cycle also had to be stopped.similar experiments with p21waf1 knockout mice (Deng et
As IFNg blocked the cell cycle at a different point thanal., 1995). LPS and dexamethasone induced the same
LPS (Vadiveloo et al., 1996), we studied whether thisdegree of apoptosis in macrophages from these mice
effect correlated with apoptosis protection. Using differ-and in those from the controls (Figure 4C). However,
ent drugs, we stopped the cell cycle of macrophages atwhereas IFNg pretreatment protected macrophages
different points, as shown by cytometric analysis (Figureagainst apoptosis in control mice, no protection was
6A) and for the time necessary to resume cell cycling
observed in the p21waf1 KO mice. Thus, p21waf1 is involved
after removal of the inhibitor (Figure 6B). After 14 hr
in the protection by IFNg against apoptosis. of treatment, mimosine stopped macrophages at the
We also analyzed whether p21Waf1 was involved in the middle-late G1, whereas aphidicolin and OH-Urea did soinhibition of proliferation by IFNg in macrophages from at the G1/S boundary and nocodazole at the G2/M phase.
these p21 KO mice (Figure 4D). Macrophages from mice Both LPS and dexamethasone induced apoptosis in
with the p21 gene disrupted proliferated 41% more than macrophages pretreated with mimosine, afidicoline, or
cells from the control mice p21Waf1 . Therefore, p21Waf1 nocodazole (Figure 6C). However, no apoptosis was in-
might be involved in regulating macrophage prolifera- duced by LPS or dexamethasone in cells treated with
tion. But IFNg still inhibited macrophage proliferation in OH-Urea (Figure 6C). As aphidicolin and OH-Urea block
these cells, although with a lower rate than in wild-type the cell cycle at a very similar point (Fox et al., 1987),
macrophages. Thus, the induction of p21Waf1 expression cell cycle arrest at the G1/S boundary is not the only
by IFNg is not necessary, as IFNg also inhibits prolifera- mechanism to protect against apoptosis. In agreement
tion in these cells. with our results that showed that the induction of p21waf1
In order to determine if p21waf1 has a pivotal role as was involved in protection against apoptosis, we ob-
an inhibitor of apoptosis, we treated macrophages with served that OH-Urea but not aphidicolin induced the
other growth and differentiating factors that have been expression of p21waf1 in macrophages; this induction cor-
described to induce the expression of p21waf1 (Chen et related with the protective effect against the induction
of apoptosis.al., 1995; Chin et al., 1996). Macrophages treated with
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of this cytokine in the negative selection by apoptosis
of the peripheral T and B lymphocyte repertoire (Liu and
Janeway, 1990; Grawunder et al., 1993). Nevertheless,
IFNg is also involved in prosurvival signals in normal
and leukemic cells (Mangan et al., 1991; Buschle et al.,
1993; Bach and Brashler, 1995; Sangfelt et al., 1996).
Therefore, depending on the target cells, IFNg can in-
duce either death or protection against apoptosis.
In this study, we found that IFNg, the immune medi-
ator that activates macrophages, protects these cells
against apoptosis. Therefore, like T and B cells, macro-
phages survive when they are useful to the immune
system and develop a functional activity after activation
by IFNg. The protection by IFNg against apoptotic stim-
uli requires the expression of p21Waf1 and the arrest of
the cell cycle in a very precise position: the G1/S bound-
ary. This is an example of interaction between prolifera-
tion, cell cycling, and apoptosis.
Experiments using antisense and p21Waf1 KO mice
demonstrated that p21Waf1 is the critical molecule in-
duced by IFNg to block apoptosis. These results are in
agreement with previous works that showed the anti-
apoptotic role of p21Waf1. The overexpression of p21Waf1
in glioma cells prevents apoptosis (Gomez-Manzano et
al., 1997). In differentiating myocytes, the expression of
p21Waf1 confers resistance against apoptosis (Wang and
Walsh, 1996). In differentiating neuroblastoma cells,
antisense oligonucleotides to p21Waf1 enhance cell death
by apoptosis (Poluha et al., 1996). Finally, the expressionFigure 5. IGF-I Increases p21Waf1 Expression in Macrophages
of p53 in a series of colorectal cancer cell lines resulted(A) BMDM were incubated with media, 250 U/ml IFNg, 20 nM EGF,
in growth arrest in some lines and apoptosis in others.or 50 nM IGF-I for 12 hr. p21Waf1 expression was determined by
The inactivation of p21Waf1 in these cells by homologousNorthern blotting. (B) IGF-I does not inhibit M-CSF-dependent prolif-
eration. BMDM were incubated in the absence (-M-CSF) or the pres- recombination changed a cell line with growth arrest
ence (1M-CSF) of 1200 U/ml M-CSF and 20 nM EGF, 50 nM IGF-I, to an apoptotic cell, suggesting that, despite inducing
or 250 U/ml IFNg for 24 hr, and then thymidine incorporation was growth arrest, p21Waf1 could protect against apoptosis
determined. (C) IGF-I does not protect macrophages against apo-
(Polyak et al., 1996). Thus, p21Waf1 seems to be a criticalptosis. BMDM pretreated for 12 hr with media (none), 250 U/ml IFNg,
molecule for the survival of cells, even with apoptotic20 nM EGF, or 50 nM IGF-I were treated with LPS (8100 ng/ml) or
stimuli. Although p21Waf1 was first described as a p53-dexamethasone (10 mg/ml). Induction of apoptosis was determined
with an ELISA kit directed against histone-associated DNA frag- induced gene (El-Deiry et al., 1993), in many cases a
ments. p53-independent expression of p21Waf1 has been found
(Parker et al., 1995; Zhang et al., 1995). This seems to
be the case of the p21Waf1 induction by IFNg in epidermal
All of these results show that both the expression of cells (Chin et al., 1996) or macrophages (data not
p21waf1 and the cell cycle arrest at the G1/S boundary shown). The induction of p21Waf1 by IFNg is mediated
induced by IFNg are required for the protection against through the interferon regulatory factor-1 (IRF-1) (Ta-
apoptosis mediated by LPS or dexamethasone. naka et al., 1996) and also through STAT1 (Chin et al.,
1996). All of these observations indicate that p21Waf1,
Discussion induced or not by p53, could play a role in the control
of apoptosis.
One of the features of the immune system is the produc- Our experiments showed that the protection of IFNg
tion of a large amount of any type of cells. Later, most against apoptosis could be related to the effect of
unnecessary cells die through apoptosis. However, the p21Waf1. Several reports have shown that the activation
small amount of cells required to develop a functional of various cdk complexes correlates with apoptosis
activity survive. In B lymphocytes, antigen receptor trig- (Meikrantz et al., 1994; Shi et al., 1994; Wei et al., 1997;
gering gives these cells a long life (Lam et al., 1997). Zhang et al., 1997). Therefore, the inhibition of these
Similarly, in the absence of appropriate MHC expression apoptotic cdk activities by cdk inhibitors like p21Waf1
in the periphery, the half-life of naive T cells is substan- could explain the protection against apoptosis induced
tially shortened. Thus, the long persistence of naive T by these molecules. However, the fact that p21Waf1 in-
cells in the absence of an intentional antigenic stimula- duced by IGF-I does not protect macrophages against
tion partially reflects the continued tickling by MHC (Tan- apoptosis suggests that the expression of p21Waf1 is by
chot et al., 1997). Moreover, the viability of the immune itself not sufficient and that complementary mecha-
cells may be regulated by the presence of growth factors nisms are necessary.
and cytokines. In this regard, the ability of IFNg to induce The protective effect of IFNg may also be caused by
the arrest of the cell cycle in a specific point, differentprogrammed cell death has been suggested as a role
IFNg Induces p21 and Blocks Induction of Apoptosis
109
Figure 6. The Macrophages at the G1/S
Boundary that Express p21Waf1 Become Re-
sistant to the Apoptotic Stimuli
BMDM were incubated with 400 mM mimo-
sine, 10 mg/ml aphidicolin, OH-Urea, or noco-
dazole for 14 hr. The position in the cell cycle
after the treatment of macrophages with cell
cycle inhibitors was determined by cytomet-
ric analysis (A) and by the time necessary for
[3H]-thymidine incorporation after withdrawal
of the inhibitor and M-CSF stimulation (B).
After synchronization, the cells were washed
and stimulated with 1200 U/ml M-CSF in the
presence of 1 mCi/ml of [3H]-thymidine. The
samples were obtained every 2 hr. (C) Macro-
phages treated with OH-Urea are unrespon-
sive to apoptotic stimuli. BMDM were incu-
bated as described in (A), washed, and then
LPS (100 ng/ml) or dexamethasone (10 mg/
ml) was added for 6 hr, and apoptosis was
determined using an ELISA kit. (D) The pro-
tective effect of OH-Urea correlates with the
expression of p21Waf1. The expression of
p21Waf1 mRNA was analyzed by Northern blot-
ting in macrophages treated for 14 hr with
each cell cycle inhibitor or with IFNg.
from that induced by LPS activation or M-CSF with- cell cycle at a very similar point. This difference could
drawal. The requirement of preincubation with IFNg may be due to the fact that OH-Urea but not aphidicolin
be related to the time necessary to stop the M-CSF- induces the expression of p21Waf1. Therefore, IFNg
proliferating macrophages and to enter in the late G1 protects macrophages against apoptosis by inducing
phase. Although c-Myc expression has been involved p21Waf1 and blocking the cell cycle at the G1/S boundary.
both in IFNg-mediated inhibition of macrophage prolifer- Both events are necessary for protection against apo-
ation (Vairo et al., 1995) and in regulation of apoptosis ptosis.
(Evan et al., 1992), our results showed that c-myc does Recently, it has also been reported that p21Waf1 pro-
not seem to be involved in the protective effect of IFNg, tects monocytes against apoptosis during its differentia-
since its expression is also inhibited by LPS. Also, the tion (Asada et al., 1999). The authors assign the protec-
role of p21Waf1 in IFNg-mediated growth arrest is unclear tive role to the cytoplasmic p21Waf1 and suggest that this
(Chin et al., 1996; Sharma and Iozzo, 1998). However, effect could be independent of that of p21Waf1 on the cell
our results with the p21Waf1 KO mice demonstrate that cycle, since they use a p21 mutant that can not enter the
although p21Waf1 could play a role in the inhibition of nucleus and thus cannot affect cell cycle progression.
macrophage proliferation, its expression is not neces- However, in normal conditions the cell cycle blockage
sary and thus other mechanisms may be involved. These induced by IFNg treatment could be responsible for this
results are in agreement with those previously published cytoplasmic localization of p21Waf1.
by Sharma and Iozzo (1998). Our results could have physiological relevance. Neu-
Blocking the cell cycle progression with inhibitors of
trophils and macrophages play a critical role during in-
cyclin-dependent kinases could make cells resistant to
flammation. Neutrophils take part in the early steps of
apoptotic stimuli. For example, the apoptotic process
the inflammatory process, leaving after 24 to 48 hr,termed T cell receptor antigen-induced cell death oc-
whereas macrophages arrive late to the inflammatorycurs at late G1 phase of the cell cycle (Lissy et al., 1998).
foci and remain there until inflammation disappears (Bel-T cells stimulated to undergo apoptosis can be rescued
lingan et al., 1996), that is, while stimulated Th1 cellsby effecting an early G1 block by direct transduction of
produce IFNg. Later, macrophages also disappear. Al-p16INK4a. Similarly, when deprived of nerve growth factor,
though both cell types are derived from the same precur-postmitotic sympathetic neurons and neuroblastoma
sor, the GM-CFU, and they share some functional activi-cells undergo apoptosis and can be rescued by trans-
ties, their roles during inflammation are totally different.fection of p16INK4a (Freeman et al., 1994; Kranenburg et
Neutrophils are primarily involved in phagocytosis andal., 1996). Moreover, apoptosis in T cells could be
destruction of the agents that cause inflammation. Al-blocked by inhibiting their progression through the S
though macrophages can phagocyte a large number ofphase treating the cells with OH-Urea (Zhu and Anasetti,
microorganisms, their primary role is to remove all cellu-1995; Dao et al., 1997).
lar debris and to induce tissue repair. Shortly after acti-The effect of IFNg on macrophage apoptosis is not
vation, the neutrophils die. The release of nuclear andonly due to an arrest of the cell cycle at the G1/S bound-
cytoplasmic components of dying cells is potentiallyary, since treatment of macrophages with OH-Urea pro-
damaging and could be related to the pathogenesistects them against apoptosis (as described in T cells);
this is not the case with aphidicolin, which blocks the of a wide range of inflammatory diseases (Malech and
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UK). As a control of RNA loading and transfer, we used a 18S rRNAGallin, 1987). The cells of the immune system are charac-
transcript (Torczynski et al., 1983).terized by their death after activation as a fine mecha-
nism of regulation of their potentially destructive activity.
Proliferation AssayThis is the case of activation-induced apoptosis through
Cell proliferation was measured as previously described (CeladaCD-3 in T cells (Zhu and Anasetti, 1995) or apoptosis
and Maki, 1992) with minor modifications. To analyze the effect of
induced by superantigen activation in lymphocytes (Et- LPS and IFNg on BMDM proliferation, the cells were deprived of
tinger et al., 1995). During the chronic phases of the M-CSF for 18 hr and then 105 BMDM were incubated for 24 hr in
24-well plates (3424 MARK II; Costar) in 1 ml of complete media inimmune response, macrophages play a crucial role, not
the presence or absence of 100 ng/ml LPS or 250 U/ml IFNg. Then,only eliminating non-self structures but also removing all
the media was removed and replaced by 0.5 ml of media containingthe debris (including apoptotic bodies) and remodeling
[3H]-thymidine (1 mCi/ml). After 2 additional hr of incubation at 378C,
injured tissues. In some instances, when non-self agents the media was removed and the cells were fixed in ice-cold 70%
cannot be eliminated, macrophages produce a granu- methanol. To analyze the time course of IFNg or LPS treatment,
after treating the cells with LPS or IFNg 1 mCi/ml [3H]-thymidine wasloma to isolate the pathogenic agents. Each granuloma
added at the indicated times, and, after 2 additional hr of incubationappears as a small spherical organ consisting of some
the cells were fixed. To analyze the time necessary to enter the Sdifferentiated macrophages, whose function is to limit
phase of the cell cycle after synchronization, the cells were treated
the expansion of intravascular bacteria and allow their for 14 hr with the indicated cell cycle inhibitors in 24-well plates in
eventual destruction (Adams, 1976; Williams and Wil- 1 ml of complete media. Once the cells were synchronized at each
phase of the cell cycle, the media was removed and the cells wereliams, 1983). In all cases, in contrast to lymphocytes
washed three times with fresh media to eliminate the inhibitors.or neutrophiles, macrophages are long-term living cells
The cells were cultured with fresh complete media containingwithin the tissues. Our observations also explain the
[3H]-thymidine (1 mCi/ml). The samples were obtained in 2 hr inter-
crucial role of IFNg on delayed hypersensitivity. vals; the media was removed and the cells were fixed. In all cases,
after fixation the cells were washed in ice-cold 10% trichloroacetic
acid (TCA) and solubilized in 1% SDS and 0.3% NaOH. Radioactivity
was counted by liquid scintillation using a 1500 Tri-Carb PackardExperimental Procedures
scintillation counter. Each point was performed in triplicate, and the
results were expressed as the mean 6 SD.Reagents
In parallel experiments, we cultured 106 macrophages in tissue-LPS, mimosine, aphidicolin, OH-Urea, and nocodazole were all ob-
cultured plates with or without 1200 U/ml of M-CSF and treatedtained from Sigma Chemical. Recombinant murine IFNg was kindly
with 300 U/ml IFNg or 100 ng/ml LPS for 24 and 48 hr. Then, thedonated by Genetech. GM-CSF, IL-3, TGFb, and IL-4 were pur-
number of surviving cells was measured by Trypan blue exclusionchased from R & D Systems. 4, 6-diamidino-2-phenylindole (DAPI)
with a hemacytometer. Again, each point was performed in triplicate,was purchased from Calbiochem. All the other products were of the
and the results were expressed as the mean 6 SD.best grade available and were purchased from Sigma Chemical.
Deionized water further purified with a Millipore Milli-Q system was
used. Analysis of DNA Content with DAPI
Cells (106) previously subjected to a specific treatment were resus-
pended and fixed in ice-cold 70% ethanol. The cells were then
Cell Culture washed in PBS, resuspended in 0.2 ml of a solution containing 150
Bone marrow±derived macrophages were isolated from 6-week-old mM NaCl, 80 mM HCl, and 0.1% Triton X-100, and incubated at
0±48C for 10 min. Afterward, 1 ml of a solution containing 180 mMBALB/c mice (Charles River Laboratories) as previously described
Na2HPO4, 90 mM citric acid, and 2 mg/ml DAPI (pH 7.4) was added(Celada et al., 1984). The cells were cultured in plastic tissue culture
to each sample. After incubating the cells at 48C for 24 hr, theirdishes (150 mm) in 40 ml DMEM containing 20% FBS and 30% L
fluorescence was measured with an Epics Elite flow cytometercell conditioned media as a source of M-CSF. The cells were incu-
(Coulter). 12000 cells were counted for each histogram, and thebated at 378C in a humidified 5% CO2 atmosphere. After 7 days of
cell cycle distributions were analyzed with the Multicycle programculture, a homogeneous population of adherent macrophages was
(Phoenix Flow Systems)obtained. Bone marrow±derived macrophages from p21Waf1 knock-
out mice were isolated in the same conditions. p21Waf1 knockout
mice (Deng et al., 1995) were kindly donated by Dr. Philip Leder Apoptosis Analysis
from Harvard Medical School (HHMI). Fragmentation of DNA due to internucleosomal cleavage was deter-
mined as described previously (Hogquist et al., 1991). In brief, 3 3
106 cells were harvested and washed in ice-cold PBS. The cells
Antibodies were lysed in 0.5 ml of lysis buffer (50 mM Tris-HCl, 10 mM EDTA,
For the analysis of p21Waf-1 and p27Kip-1 expression by Western blot- and 1% SDS [pH 8.0]) for 16 hr at 48C, and the lysates were centri-
ting, we used monoclonal anti-mouse p21Waf-1 and anti-mouse fuged (13000 3 g) to separate high molecular weight DNA (pellet)
from cleaved low molecular weight DNA (supernatant). The DNAp27Kip-1 antibodies (PharMingen). Primary antibodies against mouse
supernatants were phenol extracted twice and precipitated. Theb-actin were purchased from Sigma. A peroxidase-conjugated anti-
pellets were resuspended in Tris-EDTA buffer containing 250 mg/mlmouse IgG (Cappel, Turnhout, Belgium) was used as secondary
RNAse (Boehringer Mannheim, Mannheim, Germany). The samplesantibody. For the assay of cdk2 kinase activity, we used an anti-
were heated at 658C for 10 min and subjected to electrophoresis incdk2 (M2) antibody from Santa Cruz Biotech.
a 2% agarose gel containing ethidium bromide.
Low molecular apoptotic DNA, obtained as indicated above, was
also measured using an ELISA technique based on the detectionPlasmids and Constructs
of histone-associated DNA fragments (Cell Death detection ELISAThe pMH117 plasmid corresponding to the mouse p21Waf-1 full-length
plus, Boehringer Mannheim). Each point was performed in triplicate,cDNA cloned in pEx-lox was kindly provided by Dr. Massague (Sloan
and the results were expressed as the mean 6 SD.Kettering Institute, HHMI, New York, NY). The pET-3d plasmid corre-
sponding to the D1 cyclin cDNA was cloned in pET-12 (Xiong et al.,
1991). The pCMJ3/cdk-4 plasmid contains the full-length mouse Protein Extraction and Western Blot Analysis
cdk-4 cDNA cloned in pBluescript KS (Matsushime et al., 1992). The Total cell extracts were analyzed by Western blotting as described
(Xaus et al., 1999a), using the p21Waf1 or p27Kip1 antibodies followedmurine c-myc probe was kindly donated by Dr. Evan (ICRF, London,
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by peroxidase-conjugated anti-mouse IgG antibody. The blots were their suppression of IL-10 production. Int. Arch. Allergy. Immunol.
107, 90±92.developed with the ECL chemiluminescence system (Amersham)
and quantified by densitometric analysis. Bellingan, G.J., Caldwell, H., Howie, S.E., Dransfield, I., and Haslett,
C. (1996). In vivo fate of the inflamatory macrophage during the
Cdk2 Kinase Activity resolution of inflammation: inflammatory macrophages do not die
Kinase activity was assayed by immunoprecipitation of 150 mg of locally, but emigrate to the draining lymph nodes. J. Immunol. 157,
total protein extracts using the anti-cdk2 (M2) antibody (Santa Cruz) 2577±2585.
followed by incubation with Histone H1 and g32P-ATP. The immuno- Brady, H.J.M., Gil-GoÂ mez, G., Kirberg, J., and Berns, A.J.M. (1996).
precipitation and Histone H1 kinase assay were performed exactly Bax a perturbs T cell development and affects cell cycle entry of T
as described (Kranenburg et al., 1995). The kinase assays were cells. EMBO J. 15, 6991±7001.
resolved on a 12% SDS polyacrylamide gel, stained with Coomassie
Buschle, M., Campana, D., Carding, S.R., Richard, C., Hoffbrand,Blue to visualize the Histone H1 bands, dried, and exposed for
A.V., and Brenner, M.K. (1993). Interferon gamma inhibits apoptoticautoradiography. Where required, the bands were quantified using
cell death in B cell chronic lymphocytic leukemia. J. Exp. Med. 177,a Molecular Analyst System (Bio-Rad).
213±218.
Celada, A., and Maki, R.A. (1992). Transforming growth factor-bNorthern Blot Analysis
enhances the M-CSF and GM-CSF-stimulated proliferation of mac-Total cellular RNA was extracted with the acid guanidinium thiocya-
rophages. J. Immunol. 148, 1102±1105.nate-phenol-chloroform method (Chomczynski and Sacchi, 1987).
The Northern blot was performed as described (Xaus et al., 1999b), Celada, A., Gray, P.W., Rinderknecht, E., and Schreiber, R.D. (1984).
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script. All probes were labeled with 32P-a-dCTP (ICN Pharmaceuti- Chen, W.H., Pellegata, N.S., and Wang, P.H. (1995). Coordinated
cals) with the oligolabeling kit method (Pharmacia Biotech, Uppsala, effects of insulin-like growth factor 1 on inhibitory pathways of cell
Sweden). The bands of interest were quantified with a Molecular cycle progression in cultured cardiac muscle cells. Endocrinology
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